Beyond the Scale: Abdominal Adiposity Outperforms BMI in Predicting Outcomes for HFpEF and HFmrEF

Introduction: Redefining the Role of Adiposity in Heart Failure

For decades, the medical community has relied on Body Mass Index (BMI) as the primary tool for assessing obesity and its associated cardiovascular risks. However, in the realm of heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF), BMI has often yielded confusing results, frequently manifesting as the obesity paradox—where higher BMI appears to correlate with better survival. This paradox has long hindered risk stratification and therapeutic targeting for a population where obesity is a central driver of disease.

Recent evidence, culminating in a massive participant-level pooled analysis published in the Journal of the American College of Cardiology, suggests that the problem lies not in the relationship between adiposity and heart failure, but in the tool used to measure it. By examining abdominal-specific metrics such as waist circumference (WC) and waist-to-height ratio (WHtR), researchers have uncovered a more direct, linear relationship between fat distribution and adverse clinical outcomes, effectively challenging the diagnostic dominance of BMI.